170 related articles for article (PubMed ID: 38270308)
21. Analysis of m6A-related signatures associated with the tumor immune microenvironment and predict survival in acute myeloid leukemia.
Yuan S; Cong Z; Ji J; Zhu L; Jiang Q; Zhou Y; Shen Q; Damiani D; Xu X; Li B
Ann Transl Med; 2022 Aug; 10(16):902. PubMed ID: 36111007
[TBL] [Abstract][Full Text] [Related]
22. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.
Zhang HB; Sun ZK; Zhong FM; Yao FY; Liu J; Zhang J; Zhang N; Lin J; Li SQ; Li MY; Jiang JY; Cheng Y; Xu S; Cheng XX; Huang B; Wang XZ
Lipids Health Dis; 2022 Aug; 21(1):79. PubMed ID: 36002858
[TBL] [Abstract][Full Text] [Related]
23. Identifying prognostic biomarker related to immune infiltration in acute myeloid leukemia.
Lu W; Yu G; Li Y; Yin C; Long J; Chen X; Chen Y; Zheng Z; Lai Y; Zhou X; Xu D
Clin Exp Med; 2023 Dec; 23(8):4553-4562. PubMed ID: 37561221
[TBL] [Abstract][Full Text] [Related]
24. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia.
Du A; Wu X; Gao Y; Jiang B; Wang J; Zhang P; Zhao Q
Front Immunol; 2021; 12():789914. PubMed ID: 34887874
[TBL] [Abstract][Full Text] [Related]
25. H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
Yu L; Ji T; Liao W; Xu Y; Fang Y; Zhu Q; Nie J; Yang D
Clin Epigenetics; 2023 Mar; 15(1):43. PubMed ID: 36932439
[TBL] [Abstract][Full Text] [Related]
26. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D
BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477
[TBL] [Abstract][Full Text] [Related]
27. m
Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
[TBL] [Abstract][Full Text] [Related]
28. m
Wang L; Hu X; Liu X; Feng Y; Zhang Y; Han J; Liu X; Meng F
Front Immunol; 2022; 13():1022720. PubMed ID: 36389726
[TBL] [Abstract][Full Text] [Related]
29. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma.
Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K
Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591
[TBL] [Abstract][Full Text] [Related]
30. Development of the expression and prognostic significance of m
Xu G; Li C; Di Z; Yang Y; Liang L; Yuan Q; Yang Q; Dong X; Xu S; Wu G
Cancer Med; 2023 Mar; 12(6):7667-7681. PubMed ID: 36464884
[TBL] [Abstract][Full Text] [Related]
31. Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer.
Zhang R; Gan W; Zong J; Hou Y; Zhou M; Yan Z; Li T; Lv S; Zeng Z; Wang W; Zhang F; Yang M
Front Immunol; 2023; 14():1054700. PubMed ID: 36911744
[TBL] [Abstract][Full Text] [Related]
32. Systematic Analysis of Tumor Microenvironment Patterns and Oxidative Stress Characteristics of Endometrial Carcinoma Mediated by 5-Methylcytosine Regulators.
Dong C; Dang L; Gao X; Xu R; Zhang H; Zhang X
Oxid Med Cell Longev; 2022; 2022():6431164. PubMed ID: 36187339
[TBL] [Abstract][Full Text] [Related]
33. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
Huang X; Qiu Z; Li L; Chen B; Huang P
Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
[TBL] [Abstract][Full Text] [Related]
34. Uncovering the Association Between m
Gu X; Zhou H; Chu Q; Zheng Q; Wang J; Zhu H
Front Cell Dev Biol; 2021; 9():727935. PubMed ID: 34589490
[No Abstract] [Full Text] [Related]
35. Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma.
Xu W; Zhu W; Tian X; Liu W; Wu Y; Anwaier A; Su J; Wei S; Qu Y; Zhang H; Ye D
Front Cell Dev Biol; 2021; 9():772436. PubMed ID: 34957104
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features.
Jian J; Yuan C; Ji C; Hao H; Lu F
Clin Exp Med; 2023 Oct; 23(6):2639-2649. PubMed ID: 36645547
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemia.
Zhong FM; Yao FY; Liu J; Zhang HB; Li MY; Jiang JY; Xu YM; Yang WM; Li SQ; Zhang J; Cheng Y; Xu S; Huang B; Wang XZ
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35441668
[TBL] [Abstract][Full Text] [Related]
38. Analysis of m
Chen J; Luo X; Wang G; Zhang J; Zhang Y
Gene; 2023 Feb; 852():147052. PubMed ID: 36395970
[TBL] [Abstract][Full Text] [Related]
39. Integrated Analyses of m
Cao Q; Chen Y
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232485
[TBL] [Abstract][Full Text] [Related]
40. Identification of prognostic genes in the acute myeloid leukemia microenvironment.
Huang S; Zhang B; Fan W; Zhao Q; Yang L; Xin W; Fu D
Aging (Albany NY); 2019 Nov; 11(22):10557-10580. PubMed ID: 31740623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
